Trade in generics

07:45 EDT 28 Aug 2013 | British Medical Journal

Jamie Love, Knowledge Ecology International, and Hans Hogerzeil, director of essential medicines and pharmaceutical policies at the World Health Organization (WHO), discuss the ongoing EU trade negotiations with India. They set out their concerns that it may lead to an interruption in the supply of new generic drugs to the developing world.

Original Article: Trade in generics


More From BioPortfolio on "Trade in generics"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...